An intimate collaboration: prognostic communication with advanced cancer patients
Helft, P.R.
Journal of Clinical Ethics 17(2): 110-121
2006
ISSN/ISBN: 1046-7890 PMID: 16913145 Document Number: 600847
Document emailed within 1 workday
Related Documents
Bianco, V.; Rozzi, A.; Terenzi, S.; Campisi, C.; Di Domenico, C. 1999: The prognostic factors in cancer patients with the disease in an advanced phase Minerva Medica 90(7-8): 242-244Gasowska-Bodnar, A.; Bodnar, L.; Wcisło, G.B.; Jerzak, M.łg.M.; Szczylik, C.; Baranowski, W.ło. 2008: CA 125 regression after two cycles of neoadjuvant chemotherapy as prognostic factor in patients with advanced ovarian cancer and primary peritoneal serous cancer who underwent interval surgical cytoreduction Ginekologia Polska 79(2): 108-114
Komuro, Y.; Watanabe, T.; Hosoi, Y.; Matsumoto, Y.; Nakagawa, K.; Suzuki, N.; Nagawa, H. 2005: Prognostic significance of Ku70 protein expression in patients with advanced colorectal cancer Hepato-Gastroenterology 52(64): 995-998
Saisho, T.; Okusaka, T.; Ueno, H.; Morizane, C.; Okada, S. 2005: Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy Hepato-Gastroenterology 52(66): 1654-1658
Hu, Y.; Zhong, A.; Yang, X. 2000: Prognostic value of serum CA125 level in patients with advanced non-small cell lung cancer Zhonghua Zhong Liu Za Zhi 22(1): 30-31
Gadducci, A.; Cianci, C.; Cosio, S.; Carnino, F.; Fanucchi, A.; Buttitta, F.; Conte, P.F.; Genazzani, A.R. 2000: P53 status is neither a predictive nor a prognostic variable in patients with advanced ovarian cancer treated with a paclitaxel-based regimen Anticancer Research 20(6c): 4793-4799
Maneechawakajorn, J.; Benjawongsathien, D. 2014: Prognostic role of thyroid transcription factor-1 (TTF-1) in advanced and inoperable adenocarcinoma subtype of lung cancer among Thai patients Journal of the Medical Association of Thailand 97(Suppl 11): S11-S17
Inaji, H.; Noguchi, S.; Yamamoto, H.; Koyama, H.; Iwanaga, T.; Wada, A. 1989: Analysis of prognostic factors in patients with locally advanced breast cancer treated with intra-arterial infusion chemotherapy as an induction therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(8 Part 2): 2910-2912
Kocic, M.; Nikolic, S.; Zegarac, M.; Djurisic, I.; Soldatovic, I.; Milenkovic, P.; Kocic, J. 2016: Prognostic factors and outcomes of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer - A single tertiary institution experience Journal of BUON: Official Journal of the Balkan Union of Oncology 21(5): 1176-1183
Inal, A.; Kos, F.T.; Algin, E.; Yildiz, R.; Berk, V.; Tugba Unek, I.; Colak, D.; Colak, D.; Kucukoner, M.; Tamer Elkiran, E.; Helvaci, K.; Geredeli, C.; Dane, F.; Balakan, O.; Ali Kaplan, M.; Gok Durnali, A.; Harputoglu, H.; Goksel, G.; Ozdemir, N.; Buyukberber, S.; Gumus, M.; Ozkan, M.; Benekli, M.; Isikdogan, A. 2012: Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multicenter study Journal of BUON: Official Journal of the Balkan Union of Oncology 17(1): 102-105
Katsoulis, M.; Vorgias, G.; Panagiotides, J.; Dertimas, B.; Zis, J. 1997: The prognostic significance of second-look laparotomy in advanced ovarian cancer European Journal of Gynaecological Oncology 18(3): 200-202
Kim, B.S.; Cho, S.W.; Min, S.K.; Lee, B.H. 2011: Differences in prognostic factors between early and advanced gastric cancer Hepato-Gastroenterology 58: 107-108
Laohavinij, S.; Maneechavakajorn, J. 2004: Prognostic factors for survival in advanced non-small cell lung cancer Journal of the Medical Association of Thailand 87(9): 1056-1064
Silvestrini, R.; Daidone, M.G.; Valagussa, P.; Salvadori, B.; Rovini, D.; Bonadonna, G. 1987: Cell kinetics as a prognostic marker in locally advanced breast cancer Cancer Treatment Reports 71(4): 375-379
Tural, D.; Kivrak Salim, D.; Mutlu, H.; Erkilic, M.; Gunduz, S.; Karakurt, M.; Musri, F.; Tuna, S.; Boz, A.; Aydin, F.; Karayalcin, B.; Bozcuk, H.; Senol Coskun, H. 2015: Is there any relation between PET-CT SUVmax value and prognostic factors in locally advanced breast cancer? Journal of BUON: Official Journal of the Balkan Union of Oncology 20(5): 1282-1286
De Manzoni, G.; Guglielmi, A.; Di Leo, A.; Tomezzoli, A.; Laterza, E.; Bonfiglio, M.; Biolo, S.; Tedesco, P.; Borzellino, G. 1998: Immunohistochemical study on the prognostic value of the expression of laminin and Ki-67 receptors in advanced gastric cancer Il Giornale di Chirurgia 19(8-9): 323-328
Prausová, J.; Lohynská, R.; Kubácková, K.; Linke, Z.; Malinová, B.; Kubala, E.; Novotný, J. 2006: Preoperative radiotherapy for locally advanced rectal cancer and prognostic factors influencing outcome Neoplasma 53(3): 263-268
Baekelandt, M.; Kristensen, G.B.; Tropé, C.G.; Nesland, J.M.; Holm, R. 1999: Epidermal growth factor receptor expression has no independent prognostic significance in advanced ovarian cancer Anticancer Research 19(5c): 4469-4474
Clement, D.; Miron, L.; Marinca, M. 2007: Age-related prognostic factors and treatment results for advanced non-small cell lung cancer (NSCLC) Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 111(4): 856-863
Tokunaga, Y.; Nakagami, M.; Tokuka, A.; Ohsumi, K. 2003: Prognostic effects of dihydropyrimidine dehydrogenase in advanced colorectal cancer after surgery: immunohistochemistry using a new monoclonal antibody Anticancer Research 23(2C): 1763-1768